Home Coronavirus COVID-19 Johnson & Johnson Covid-19 Vaccine: 66% Effective in Global Trial, but 85%... Johnson & Johnson Covid-19 Vaccine: 66% Effective in Global Trial, but 85% Against Severe Disease January 29, 2021 You are unauthorized to view this page. Username or E-mail Password Remember Me Forgot Password RELATED ARTICLESMORE FROM AUTHOR Pope Francis Dies at 88, Vatican Announces SAVE Act, Which Eliinates Expat Voting, Passes US House Jalisco Strengthens Global Ties Through Tech, Tequila, and Tourism Sheinbaum and Trump Hold Phone Conference U.S. to Impose 21% Tariff on Mexican Tomatoes Starting in July
